Outlook for a dengue vaccine

Clinical Microbiology and Infection

Volumn 20, Issue S5, 2014, Pages 92-94

  Norrby, R ^a  

^a International Vaccine Institute   (South Korea)

Author keywords

Clinical trial; Dengue; Dengue epidemiology; Dengue haemorrhagic fever; Dengue vaccine

Indexed keywords

DENGUE VACCINE; YELLOW FEVER VACCINE;

DENGUE; HUMAN; IMMUNE RESPONSE; INCIDENCE; MORTALITY; PHASE 3 CLINICAL TRIAL (TOPIC); POPULATION; PRIORITY JOURNAL; PROTECTION; REVIEW; SEROTYPE; THAILAND; VIRUS ATTENUATION; DENGUE VIRUS; IMMUNOLOGY; RANDOMIZED CONTROLLED TRIAL (TOPIC);

DENGUE VIRUS;

CLINICAL TRIALS, PHASE III AS TOPIC; DENGUE; DENGUE VACCINES; DENGUE VIRUS; HUMANS; RANDOMIZED CONTROLLED TRIALS AS TOPIC;

EID: 84897544725     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1111/1469-0691.12442     Document Type: Review

References (5)

1. Guy B, Saville M, Lang J. Development of Sanofi Pasteur tetravalent dengue vaccine. Hum Vaccin 2010; 6: 696-705.
2. Poo JL, Galán Herrera JF, Forrat R, Zambrano B, Lang J, Dayan G. Live-attenuated tetravalent dengue vaccine in Dengue-naive children, adolescents and adults in Mexico city: randomized controlled phase 1 trial of safety and immunogenicity. Pediatr Infect Dis J 2011; 30: e9-e17.
3. Sabachareon A, Sirivichayakul C, Limkittikul K et al. Protective efficacy of the recombinant, live-attenuated CYD tetravalent dengue vaccine in Thai schoolchildren: a randomized, controlled Phase 2b trial. Lancet 2012; 380: 1559-1567.
4. Sabchareon A, Sirivichayakul C, Limkittikul K et al. Dengue infection in Rathchaburi, Thailand: a cohort study. I Epidemiology of symptomatic acute dengue infection in children, 2006-2009. PLOS Negl Trop Dis 2012; 6: e1732.
5. Sirivichayakul C, Limkittikul K, Chantavanich P et al. Dengue infection in children in Ratchaburi, Thailand: a cohort study. II. Clinical manifestations. PLOS Negl Trop Dis 2012; 6: e1520.